<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Hepatitis News</title> 
<link>http://www.mdlinx.com/IDLinx/news.cfm/newspage/1/spec_id/12/subspec_id/130</link> 
<description>Hepatitis</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-alpha and Ribavirin Treatment]]></title> 
<link>http://www.mdlinx.com/IDLinx/xml-article.cfm/2941312</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Journal of Immunology</b>]]></description> 
<guid>http://www.mdlinx.com/IDLinx/xml-article.cfm/2941312</guid>
</item> 
 

<item> 
<title><![CDATA[Pharmacotherapy of chronic hepatitis C virus infection ? the IDEAL trial: 2b or not 2b (= 2a), that is the question]]></title> 
<link>http://www.mdlinx.com/IDLinx/xml-article.cfm/2944501</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Expert Opinion in Pharmacotherapy</b>]]></description> 
<guid>http://www.mdlinx.com/IDLinx/xml-article.cfm/2944501</guid>
</item> 


 

<item> 
<title><![CDATA[Generation of Full-Length Functional Antibody against PreS2 of Hepatitis B Virus in Hepatic Cells In Vitro from Bicistrons Mediated by Gutless Adenovirus]]></title> 
<link>http://www.mdlinx.com/IDLinx/xml-article.cfm/2947358</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>BioDrugs</b>]]></description> 
<guid>http://www.mdlinx.com/IDLinx/xml-article.cfm/2947358</guid>
</item> 
 
 


  


</channel> 
</rss>

